Beam is trading like it’s 2021
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Category: research
Meet the contenders for the STAT Madness 2024 crown. Voting begins March 1
The 64 contestants whose discoveries and innovations have been selected for the 2024 edition of…
Q&A: The scientific integrity sleuth taking on the widespread problem of research misconduct
Elisabeth Bik, a microbiologist by training, has become one of the world’s most influential science…
STAT+: Pharmalittle: We’re reading about Congress punts PBM reform, another obesity drug and more
Rise and shine, everyone, another busy day is on the way. Sadly, gray skies are…
GSK pill works in uncomplicated gonorrhea
Want to stay on top of the science and politics driving biotech today? Sign up to get…
.jpg)
STAT+: MD Anderson tried — and failed — to resolve research credit dispute between two scientists, new documents show
Early last year, MD Anderson Cancer Center leadership had a problem on their hands: a…
The FDA isn’t afraid to yank a disappointing drug
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Novavax’s money is going in the wrong direction
Want to stay on top of the science and politics driving biotech today? Sign up to get…
War zone or not, Ukraine seeks to reclaim its role as a hub for clinical trials
In the years leading up to Russia’s invasion, Ukraine had become a burgeoning hub of…
.jpg)
Presidential age debate obscures a simple fact: Some cognitive skills improve as we get older
When a psychology professor in Michigan looked through his data on interpersonal conflict a decade…
Small study adds to growing hope CAR-T cell therapy could revolutionize autoimmune disease treatment
People with autoimmune disorders don’t usually get to talk about a cure. There’s symptom management,…
STAT+: Scientists take a (small) step toward universal antivenom
Antivenom, like Mexican Coke or grandma’s cookies, is still made the old-fashioned way. In antivenom’s…
NIH study of ME/CFS points to immune dysfunction and brain abnormalities at core of long-dismissed disease
Alison Sbrana was in the belly of an opera when her life changed. Down in…
Bayer, short on cash, reaches into shareholders’ pockets
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Phage therapy: Researchers sharpen another arrow in the quiver against antibiotic resistance
Lynn Cole was in a never-ending cycle of getting recurrent blood infections. And no antibiotic…
Opinion: New CMS rules will throttle access researchers need to Medicare, Medicaid data
Groundbreaking research more than a decade ago showed that almost one-fifth of people enrolled in…
Niacin has long been a public health darling. But an excess could be bad for the heart, study suggests
Niacin, or vitamin B3, has long been a U.S. public health darling to the point…
STAT+: Opioid cravings were reduced by anti-obesity drug in small study
DENVER — The GLP-1 medication liraglutide significantly reduced opioid cravings in a small analysis presented on…
STAT+: Leading MD Anderson oncologist disputes junior scientist’s claims in lawsuit over research credit
Prominent immunologist and oncologist Padmanee Sharma defended herself in court on Friday against a lawsuit…
More people die after smoking drugs than injecting them, study finds
NEW YORK — Smoking has surpassed injecting as the most common way of taking drugs…
Alnylam thickened the plot
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Solving astronauts’ health challenges in deep space could have payoffs on Earth
Space is famously known as the final frontier for human exploration. It may also be…
Lyme disease cases rise, but largely due to a change in data collection
A new report released Thursday by the Centers for Disease Control and Prevention appears to…
Abortion pills offered via telehealth as safe as in-person medication abortions, study finds
With the Supreme Court just a month away from hearing arguments over access to the…
Pharma’s contractors might finally be on the rebound
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: The Jewish American and Palestinian American scientists who’ve been partnering for 14 years on science’s toughest challenges
WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads…
STAT+: Digital tools helped lower blood pressure in marginalized patient groups
If you have high blood pressure, it’s increasingly likely that your doctor or your insurer…
Smoking impairs immune response, even after quitting, new study says
Public health messages have told us for decades that if you smoke, you should quit….
Replicate’s srRNA rabies vaccine effective in Phase 1
Want to stay on top of the science and politics driving biotech today? Sign up to get…
The need to know biotech news stories today
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Opinion: STAT+: A California court is setting a dangerous precedent over drug development (or lack thereof) liability
The assault on the development of new lifesaving therapies continues apace. Recently, the First Appellate…
Stem cell study offers clue to South Asians’ increased risk of cardiovascular disease
A growing body of data show that South Asians are at greater risk of developing…
Ebola vaccine cuts fatality even in people who were infected before the jab, new study shows
A new study has shown that people vaccinated against Ebola who still developed the disease…
Psychedelic investment continues to ramp up
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: A flurry of research misconduct cases has universities scrambling to protect themselves
There was a time when an allegation of data mishandling, scientific misconduct, or just a…
Does Moderna’s RSV vaccine lose efficacy faster than others?
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: A junior scientist. A prominent oncologist. Now, a clash at MD Anderson over who gets research credit
Three years ago, Jamie Lin, an early-career nephrologist at MD Anderson Cancer Center, made findings…
Higher naloxone doses have no impact on overdose survival, study shows
People receiving a double dose of naloxone are no more likely to survive an opioid…
Studies cited in abortion pill case are retracted due to flaws and conflicts of interest
A medical journal has retracted two studies claiming to show the harms of the abortion…
Could testosterone be a useful treatment for menopause?
The world may be getting over the idea that men are from Mars and women…
Can exercise help treat long Covid? New study finds patients improve with self-paced approach
Fatigue leads the list of persistent problems experienced by people with long Covid — which…
STAT+: Mystery of allergic memory gets closer to answer: a rare group of B cells
Maria Curotto de Lafaille’s lab was trying to make human plasma cells in a dish….
Vertex still knows how to do what it does best
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Regeneron is interested in obesity treatments that combat muscle loss
Want to stay on top of the science and politics driving biotech today? Sign up to get…
What makes a drug a blockbuster — or a cautionary tale?
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Opinion: Can Arena Bioworks upend the traditional scientific research model in the U.S.?
I’ve spent a good deal of my career thinking about how we structure and fund…
Medicare drug price negotiation’s day in court
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
Clues from mice could help explain why women face a higher risk of autoimmune disorders
Researchers have long known that women are more likely to develop autoimmune disorders than men,…
Novavax is on thin ice, and the latest update isn’t exactly encouraging
Want to stay on top of the science and politics driving biotech today? Sign up to…
STAT+: Obscure vertigo drug could bring rare hope for patients with devastating neuron disease
About a decade ago, Tatiana Bremova-Ertl’s graduate adviser was studying an obscure, 1950s-era French vertigo…